Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- Check7 days agoChange DetectedThe page footer/site revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/UI version change rather than any change to the trial information.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a metadata/maintenance change and does not affect study details.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a versioning update rather than a modification to study content.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.2 was applied; there are no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1; this is a minor maintenance update that does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.